Evidence map›Paper›PMID 41155125›Full record

ArticleBioengineering (Basel, Switzerland)2025

AI-RiskX: An Explainable Deep Learning Approach for Identifying At-Risk Patients During Pandemics.

Nada Zendaoui, Nardjes Bouchemal, Mohamed Rafik Aymene Berkani, Mounira Bouzahzah, Saad Harous, Naila Bouchemal

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nada ZendaouiInstitute of Mathematics and Computer Science, Abdelhafid Boussouf University Center of Mila, Mila 43000, Algeria.ORCID 0000-0001-6055-0854
Nardjes BouchemalInstitute of Mathematics and Computer Science, Abdelhafid Boussouf University Center of Mila, Mila 43000, Algeria.ORCID 0000-0001-6105-2152
Mohamed Rafik Aymene BerkaniLSEA Research Laboratory in Advanced Electronics Systems, University Yahia Fares of Medea, Medea 26000, Algeria.
Mounira BouzahzahInstitute of Mathematics and Computer Science, Abdelhafid Boussouf University Center of Mila, Mila 43000, Algeria.ORCID 0000-0002-4950-191X
Saad HarousDepartment of Computer Science, College of Computing and Informatics, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.ORCID 0000-0001-6524-7352
Naila BouchemalLyRIDS ECE Ecole d'Ingénieurs de Paris, 75015 Paris, France.ORCID 0000-0001-8294-9276

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pandemics place extraordinary pressure on healthcare systems, particularly in identifying and prioritizing high-risk groups such as the elderly, pregnant women, and individuals with chronic diseases. Existing Artificial Intelligence models often fall short, focusing on single diseases, lacking interpretability, and overlooking patient-specific vulnerabilities. To address these gaps, we propose an Explainable Deep Learning approach for identifying at-risk patients during pandemics (AI-RiskX). AI-RiskX performs risk classification of patients diagnosed with COVID-19 or related infections to support timely intervention and resource allocation. Unlike previous models, AI-RiskX integrates five public datasets (asthma, diabetes, heart, kidney, and thyroid), employs the Synthetic Minority Over-sampling Technique (SMOTE) for class balancing, and uses a hybrid convolutional neural network-long short-term memory model (CNN-LSTM) for robust disease classification. SHAP (SHapley Additive exPlanations) enables both individual and population-level interpretability, while a post-prediction rule-based module stratifies patients by age and pregnancy status. Achieving 98.78% accuracy, AI-RiskX offers a scalable, interpretable solution for equitable classification and decision support in public health emergencies.

Indexed as

artificialintelligenceat-risk patientCNNdecision makingdeep learningexplainable artificial intelligenceLSTM

Identifiers

PMID41155125
PMCPMC12561413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.